Assessment of liver stiffness measurement-related markers in predicting liver-related events in viral cirrhosis with clinically significant portal hypertension

Figure 3 Cumulative incidence of liver-related events in compensated viral cirrhosis patients with clinically significant portal hypertension. A: Cumulative incidence of decompensation events in patients stratified by liver stiffness measurement (LSM) risk groups (≥ 25.25 kPa vs < 25.25 kPa), LSM-platelet ratio (LPR) risk groups (≥ 0.35 vs < 0.35), and LSM-albumin ratio (LAR) risk groups (≥ 0.57 vs < 0.57) in the training cohort; B: Cumulative incidence of decompensation events in patients stratified by LSM risk groups (≥ 25.25 kPa vs < 25.25 kPa) , LPR risk groups (≥ 0.35 vs < 0.35), and LAR risk groups (≥ 0.57 vs < 0.57) in the validation cohort.